Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
107 hedge funds and large institutions have $152M invested in Infinity Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 14 closing their positions.
208% more call options, than puts
Call options by funds: $5.11M | Put options by funds: $1.66M
79% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 14
16% more capital invested
Capital invested by funds: $131M → $152M (+$21.2M)
10% more funds holding
Funds holding: 97 → 107 (+10)
0% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$7.71M |
| 2 |
D.E. Shaw & Co
New York
|
+$6.53M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$5.11M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.62M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$1.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$11.3M |
| 2 |
ACM
Altium Capital Management
New York
|
-$2.79M |
| 3 |
Renaissance Technologies
New York
|
-$2.07M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$1.55M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.14M |
INFI Hedge Fund Activity: Q3 2021 in Review
107 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q3 2021, worth a combined $152M — up 16% from $131M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new INFI positions and 14 closed out — a net gain of 11 holders — while 29 added to existing stakes and 29 trimmed.
The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $7.71M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $11.3M sold.
- 107 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q3 2021, up from 97 in Q2 2021.
- Funds reported $152M of Infinity Pharmaceuticals, Inc. stock for Q3 2021, up 16% quarter-over-quarter.
- 25 funds opened new Infinity Pharmaceuticals, Inc. positions in Q3 2021 and 14 closed out, a net change of +11 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q3 2021 was Polar Capital Holdings, an estimated $7.71M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q3 2021 was Consonance Capital Management, an estimated $11.3M sold.
Based on aggregated 13F filings for Q3 2021.